Resources

Brainomix announced new data published in the esteemed American Journal of Respiratory & Critical Care Medicine (AJRCCM)

Brainomix, a global leader in AI-powered imaging for stroke and lung disease, today announced that five abstracts showcasing its proprietary biomarkers and advanced CT analysis technologies will be presented at the European Respiratory Society (ERS) Congress 2026, taking place September 5–9 in Barcelona, Spain.

Chris Molloy on mRNA cancer vaccine reaching Phase 3 milestone, Scancell MHRA authorisation, microbiome-based medicinal products, MHRA voucher scheme for SMEs, Scotland and data driver projects

AI may be biotech’s biggest opportunity, but without the right data infrastructure, even the smartest models risk getting stuck at pilot stage

The advantages to building a business in the UK's biotech clusters

Each month, our Policy and Public Affairs team will showcase how we are championing members’ voices in Government and Parliament.

Up to $110 million upfront and success-based milestones collaboration will generate large-scale human cellular perturbation datasets to advance understanding of disease biology.

The UK’s innovative life sciences sector has called on Government to deliver policy continuity, unlock scale-up investment and improve patient access to new medicines.

BIO 2026, UK-China relations, EU biosolutions, TechBio X, expanding overseas and BIA Summer Party

New AI infrastructure, the MHRA AI Sandbox, life science leadership, global advocacy and BIA’s upcoming events

New AI sandbox will help make medicines safer, speed up development, and reduce reliance on animal testing.

Driven by world-class science and monumental funding, the UK TechBio sector is undergoing a profound paradigm shift –​​​​​​​​​​​ meet the innovative BIA members leading the charge

Chris Molloy discusses Government engagement, the King’s Speech, health data, Isomorphic’s huge raise, the Start-up Festival and expanding BIA’s reach

Cell and Gene Therapy Catapult (CGT Catapult) will provide investment to Lir Therapeutics (Lir) to accelerate the development of nAAVigator, its AI-driven AAV capsid design platform.

Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline.

Brainomix announces an expansion of its partnership with Boehringer Ingelheim to improve the care of patients with progressive pulmonary fibrosis (PPF).

BIA calls for coordinated action and a clear mandate for Health Data Research Service (HDRS) to prioritise UK value creation with health innovators and job creators, a key sector for economic growth

It has been an extremely challenging time for biotech post COVID-19 boom, but our Q1 financing report offers hope with continued positive momentum.

Outpost Bio has raised $3.5 million in pre-seed funding to build frontier AI models that make human microbiology computable, enabling more precise prediction and optimization of intervention outcomes.